Cargando…
Fetal Down syndrome screening models for developing countries; Part II: Cost-benefit analysis
BACKGROUND: To identify the most cost-beneficial model as a national policy of screening and diagnosis of fetal Down syndrome (DS) in developing countries. METHODS: Cost-benefit analysis (CBA) was performed based on the effectiveness and probabilities derived from a large prospective study on MSS (m...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880440/ https://www.ncbi.nlm.nih.gov/pubmed/31775720 http://dx.doi.org/10.1186/s12913-019-4699-4 |